RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        폐렴구균 DNA 백신의 유효성 평가

        이주희(Jue Hee Lee),한용문(Youngmoon Han) 대한약학회 2005 약학회지 Vol.49 No.6

        Streptococcus pneumoniae is the leading cause of pneumonia and bacterial meningitis. The current polysaccharide vaccine has been reported ineffective in elderly adults and children less than 2 years of age. Thus, in recent many researchers have been focusted on a different approach, DNA vaccine. In our laboratory, we developed a Streptococcus pneumoniae DNA(SPDNA) vaccine. This SPDNA vaccine was formulated by inserting the resion encoding part of the capsule in the S.pneumoniae into the LAMP-1. In present work, with use of the SPDNA vaccine we attmpted to to establish a certain methodology useful for evaluation of effectiveness and immunoresponse of a DNA vaccine. Results showed that the subcutaneous route was the most effective for production of antisera specific for S. pneumoniae in mice. By isotyping analyses, IgM, IgG1, IgG2a, and IgG2b were determined. In addition, INF-γ and IL-4 were predominantly detected. Combination of those data resulted in a pattern of IgG1IL-4, which indicates the immunity towards the Th1 response predominantly. Furthermore, the SPDNA vaccination induced resistance of the CD4+T lymphocyte-depleted mice against disseminated pneumococcal infection. These data appear to be possibly due to activation of CD8+T cell-activation. Taken together, this methodology can be applied for evaluating efficacy and mode of action of a DNA vaccine as minimum criteria.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼